Chargement en cours...
New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection
Chronic hepatitis B (CHB) affects over 350 million individuals worldwide and is the most common cause of liver cancer. In the United States, CHB affects at least 2 to 3 million individuals, and current therapies can control the disease but not cure it. There are over 30 new molecules being studied i...
Enregistré dans:
| Publié dans: | Gastroenterol Hepatol (N Y) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Millennium Medical Publishing
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5495044/ https://ncbi.nlm.nih.gov/pubmed/28690451 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|